The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical factors affecting HE4 and CA125 in women at high risk of developing ovarian cancer.
Archana Raamanathan
No relevant relationships to disclose
Laura L. Holman
No relevant relationships to disclose
Diana L Urbauer
No relevant relationships to disclose
Keith A. Baggerly
No relevant relationships to disclose
Yu Shen
No relevant relationships to disclose
Robert C. Bast
Consultant or Advisory Role - Vermillion
Other Remuneration - Fujirebio Diagnostics
Karen H. Lu
No relevant relationships to disclose